or Try an Advanced Search...

    Technical Analysis for MGRX - Mangoceuticals, Inc.

    Grade Last Price % Change Price Change
    D 0.25 -2.87% -0.01
    MGRX closed down 7.93 percent on Wednesday, May 8, 2024, on 7 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical MGRX trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish -2.87%
    Bollinger Band Squeeze Range Contraction -2.87%
    Outside Day Range Expansion -2.87%
    Gapped Down Weakness -2.87%
    Crossed Above 20 DMA Bullish -10.58%
    Bollinger Band Squeeze Range Contraction -10.58%
    NR7 Range Contraction -10.58%
    20 DMA Resistance Bearish -4.25%
    Bollinger Band Squeeze Range Contraction -4.25%
    Outside Day Range Expansion -4.25%
    Older End-of-Day Signals for MGRX ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 2 hours ago
    60 Minute Opening Range Breakout about 3 hours ago
    Down 3% about 3 hours ago
    Down 2 % about 3 hours ago
    20 DMA Resistance about 3 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MGRX Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
    Classification
    Sector: Healthcare
    Industry: Health Information Services
    Keywords: Telehealth Telemedicine Wellness Products Erectile Dysfunction

    Is MGRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 2 Mangoceuticals granted 180-day extension to meet minimum bid price requirement
    May 2 Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement
    Apr 25 Mangoceuticals acquires a global patent portfolio
    Apr 25 Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care
    Apr 23 Mangoceuticals files to sell 30M shares of common stock for holders
    Apr 12 Mangoceuticals signs deal for initial development of erectile dysfunction products in Mexico
    Apr 12 Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products
    Apr 10 This Mangoceuticals Insider Increased Their Holding In The Last Year
    Mar 20 Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
    Feb 13 MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY
    See more MGRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.38
    52 Week Low 0.143
    Average Volume 605,461
    200-Day Moving Average 0.57
    50-Day Moving Average 0.23
    20-Day Moving Average 0.27
    10-Day Moving Average 0.26
    Average True Range 0.03
    RSI (14) 50.00
    ADX 11.85
    +DI 18.11
    -DI 16.06
    Chandelier Exit (Long, 3 ATRs) 0.22
    Chandelier Exit (Short, 3 ATRs) 0.29
    Upper Bollinger Bands 0.30
    Lower Bollinger Band 0.24
    Percent B (%b) 0.34
    BandWidth 22.94
    MACD Line 0.01
    MACD Signal Line 0.01
    MACD Histogram -0.0023
    Fundamentals Value
    Market Cap 5.67 Million
    Num Shares 22 Million
    EPS -0.44
    Price-to-Earnings (P/E) Ratio -0.59
    Price-to-Sales 12.35
    Price-to-Book 6.49
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.30
    Resistance 3 (R3) 0.30 0.30 0.29
    Resistance 2 (R2) 0.30 0.28 0.29 0.29
    Resistance 1 (R1) 0.28 0.28 0.27 0.27 0.29
    Pivot Point 0.27 0.27 0.26 0.26 0.27
    Support 1 (S1) 0.25 0.26 0.24 0.24 0.23
    Support 2 (S2) 0.24 0.25 0.24 0.22
    Support 3 (S3) 0.22 0.24 0.22
    Support 4 (S4) 0.22